FRNM - FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
FRNM - FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.